Anti-annexin A5 antibodies in reproductive failures in relation to antiphospholipid antibodies and phosphatidylserine

American Journal of Reproductive Immunology

Volumn 50, Issue 3, 2003, Pages 202-208

  Arai, T ^a   Matsubayashi, Hidehiko ^a   Sugi, T ^a   Kondo, A ^a   Shida, M ^a   Suzuki, T ^a   Izumi, S I ^a   McIntyre, J A ^b   Makino, T ^a  

^a TOKAI UNIVERSITY   (Japan)

^b St Francis Hospital   (United States)

Author keywords

Annexin A5; Anticoagulation; Implantation failures; Lupus anticoagulant; Phospholipids; Pregnancy loss

Indexed keywords

ANTIBODY; EPITOPE; IMMUNOGLOBULIN ANNEXIN A5 ANTIBODY; LIPOCORTIN 5; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIGENICITY; ARTICLE; BINDING KINETICS; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PREGNANCY; PREGNANCY DISORDER; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECURRENT ABORTION; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS; TREATMENT FAILURE; TROPHOBLAST;

ABORTION, SPONTANEOUS; ANNEXIN A5; ANTIBODIES; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PHOSPHATIDYLSERINES; PREGNANCY;

EID: 0041425259     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0897.2003.00069.x     Document Type: Article

References (43)

1. Reutelingsperger CPM, Hornstra G, Hemker HC: Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985; 151:625-629.
2. Morgan RO, Jenkins NA, Gilbert DJ, Copeland NG, Balsara BR, Testa JR, Fernandez MP: Novel human and mouse annexin A10 are linked to the genome duplications during early chordate evolution. Genomics 1999; 60:40-49.
3. Tait JF, Gibson D, Fujikawa K: Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989; 264:7944-7949.
4. Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K: Human placental anticoagulant protein: Isolation and characterization. Biochemistry 1987; 26:5572-5578.
5. Tait JF, Gibson D: Phospholipid binding of annexin V: Effect of calcium and membrane phosphatidylserine content. Archives Biochem Biophys 1992; 298:187-191.
6. Andree HAM, Stuart MCA, Hermens WT, Reutelingsperger CPM, Hemker HC, Frederik PM, Willems GM: Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 1992; 267:17,907-17,912.
7. Tait JF, Sakata M, McMullen BA, Miao CH, Funakoshi T, Hendrickson LE, Fujikawa K: Placental anticoagulant proteins: Isolation and comparative characterization of four members of the lipocortin family. Biochemistry 1988; 27:6268-6276.
8. Reutelingsperger CPM, Van Heerde WL: Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 1997; 53:527-532.
9. Tzima E, Trotter PJ, Orchard MA, Walker JH: Annexin V binds to the actin-based cytoskeleton at the plasma membrane of activated platelets. Exp Cell Res 1999; 251:185-193.
10. Balch C, Dedman JR: Annexins II and V inhibit cell migration. Exp Cell Res 1997; 237:259-263.
11. Flaherty MJ, West S, Heimark RL, Fujikawa K, Tait JF: Placental anticoagulant protein-I: Measurement in extracellular fluids and cells of the hemostatic system. J Lab Clin Med 1990; 115:174-181.
12. Romisch J, Heimburger N: Purification and characterization of six annexins from human placenta. Biol Chem Hoppe-Seyler 1990; 5:383-388.
13. Krikun G, Lockwood CJ, Wu X-X, Zhou X-D, Guller S, Calandri C, Guha A, Nemerson Y, Rand JH: The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: Immunolocalization and in vitro regulation. Placenta 1994; 15:601-612.
14. Rote NS, Vogt E, DeVere G, Obringer AR, Ng A-K: The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J Reprod Immunol 1998; 39:125-136.
15. Rand JH, Wu XX, Andree HAM, Lockwood CJ, Guller S, Scher J, Harper PC: Pregnancy loss in the antiphospholipid-antibody syndrome: A possible thrombogenic mechanism. New Engl J Med 1997; 337:154-160.
16. Vogt E, Ng AK, Rote NS: Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol 1997; 177:964-972.
17. Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M: Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol 1994; 47:56-58.
18. Rodriguez-Garcia MI, Fernandez JA, Rodriguez A, Fernandez MP, Gutierrez C, Torre-Alonso JC: Annexin V autoantibodies in rheumatoid arthritis. Ann Rheum Dis 1996; 55:895-900.
19. Gris JC, Quere I, Sanmarco M, Boutiere B, Mercier E, Amiral J, Hubert A-M, Ripart-Neveu S, Hoffet M, Tailland M-L, Rousseau O, Monpeyroux F, Dauzat M, Sampol J, Daures J-P, Berlan J, Mares P: Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nimes Obstetricians and Haematologists Study-NOHA. Thromb Haemost 2000; 84:228-236.
20. Matsubayashi H, Arai T, Izumi S-I, Sugi T, McIntyre JA, Makino T: Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 2001; 76:694-699.
21. Nakao H, Watanabe M, Maki M: A new function of calphobindin I (annexin V). Promotion of both migration and urokinase-type plasminogen activator activity of normal human keratinocytes. Eur J Biochem 1994; 223:901-908.
22. Kuragaki C, Kidoguchi K, Nakamura N, Wada Y: Anti-annexin V antibodies in plasma and serum samples from patients with lupus anticoagulant [letter]. Am J Hematol 1995; 50:68.
23. Matsubayashi H, Sugi T, Arai T, Kondo A, Suzuki T, Izumi S-I, McIntyre JA, Makino T: Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients. Am J Reprod Immunol 2001; 46:323-329.
24. Sugi T, Katsunuma J, Izumi S-I, McIntyre JA, Makino T: Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertil Steril 1999; 71:1060-1065.
25. Ogasawara M, Aoki K, Katano K, Aoyama T, Kajiura S, Suzumori K: Prevalence of autoantibodies in patients with recurrent miscarriages. Am J Reprod Immunol 1999; 41:86-90.
26. Thiagarajan P, Pengo V, Shapiro SS: The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulant. Blood 1986; 68:869-874.
27. Wagenknecht DR, Sugi T, McIntyre JA: The evolution, evaluation and interpretation of antiphospholipid antibody assays. Clin Immunol Newsletter 1995; 15:28-38.
28. Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Iwatani Y, Kanakura Y: Association between the prevalence of antibodies to β 2-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 2001; 47: 1008-1015.
29. Ogawa H, Zhao D, Dlott JS, Cameron GS, Yamazaki M, Hata T, Triplett DA: Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities. Am J Clin Pathol 2000; 114:619-628.
30. Nakamura N, Kuragaki C, Shidara Y, Yamaji K, Wada Y: Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties. Am J Hematol 1995; 49:347-348.
31. Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H: Anti-beta 2 glycoprotein I and anti-annexin antibodies in women with recurrent miscarriage. Br J Haematol 2001; 113:911-914.
32. Brisson A, Mosser G, Huber R: Structure of soluble and membrane-bound human annexin V. J Mol Biol 1991; 220:199-203.
33. Mosser G, Ravanat C, Freyssinet J-M, Brisson A: Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J Mol Biol 1991; 217:241-245.
34. Satoh A, Suzuki K, Takayama E, Kojima K, Hidaka T, Kawakami M, Matsumoto I, Ohsuzu F: Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 1999; 26:1715-1720.
35. Obringer AR, Dean KW, Channel SR, Rote NS: Aminophospholipid translocase activity in JEG-3; A choriocarcinoma model of cytotrophoblast differentiation. Placenta 1997; 18:421-426.
36. Zwaal RFA, Schroit AJ: Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89:1121-1132.
37. Adler RR, Ng AK, Rote NS: Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995; 53:905-910.
38. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS: Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997; 56:50-58.
39. Romisch J, Seiffge D, Reiner G, Paques EP, Heimburger N: In-vivo antithrombotic potency of placenta protein 4 (annexin V). Thromb Res 1991; 61:93-104.
40. Ryn-McKenna JV, Merk H, Muller TH, Buchanan MR, Eisert WG: The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits. Thromb Haemost 1993; 69:227-230.
41. Wang X, Campos B, Kaetzel MA, Dedman JR: Annexin V is critical in the maintenance of murin placental integrity. Am J Obstet Gynecol 1999; 180:1008-1016.
42. Di Simone N, Castellani R, Caliandro D, Caruso A: Monoclonal anti-annexin V inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 2001; 65:1766-1770.
43. Nakamura N, Ban T, Yamaji K, Yoneda Y, Wada Y: Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset. J Clin Invest 1998; 101:1951-1959.